Clinical Trials Logo
  1. Home
  2. Obstructive Jaundice
  3. NCT05928286

Remaxol® Used in the Treatment of Patients With Gallstone Disease Complicated With Obstructive Jaundice

Obstructive Jaundice Clinical Trial

Official title:
Observational Study of Efficiency of the Drug Remaxol® (Inosine + Meglumine + Methionine + Nicotinamide + Succinic Acid) Used in the Treatment of Patients With Gallstone Disease Complicated With Obstructive Jaundice

Clinical Trial Summary

Obstructive jaundice is observed in 10-80 % of gallstone disease cases. The conventional tactics for the management of patients with obstructive jaundice is to remove biliary hypertension by using endoscopic or minimally invasive methods. The final surgical treatment is performed after jaundice reduction and normalization of hepatic functions. We suppose that the administration of the drug Remaxol (Inosine + Meglumine + Methionine + Nicotinamide + Succinic acid) during the perioperative period shortens jaundice duration and decreases the complications rate.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05928286
Study type Observational
Source POLYSAN Scientific & Technological Pharmaceutical Company
Contact Alexey Kovalenko, Doc Biol Sci
Phone +78127108225
Email science@polysan.ru
Status Recruiting
Phase
Start date December 1, 2022
Completion date March 2024
View Details
See also
  Status Clinical Trial Phase
Completed NCT01506115 - Safety and Efficacy of Photodynamic Therapy for Bile Duct Invasion of Hepatocellular Carcinoma N/A
Completed NCT00409864 - Endoscopic Versus Percutaneous Drainage For Hilar Block in Gall Bladder Cancer N/A
Not yet recruiting NCT06093048 - Endoscopic Retrograde Cholangiopancreatography In Patients Older Than 65Years Old With Obstructive Jaundice: Efficacy And Outcome N/A
Completed NCT02468076 - Radiofrequency Ablation for Biliopancreatic Malignancy Phase 2
Not yet recruiting NCT03491254 - Investigating the Efficacy and Safety of the Combination Treatment of Huaier Granule and Biliary Drainage for MOJ
Recruiting NCT02797665 - Treatment of Obstructive Jaundice in Autoimmune Pancreatitis and/or Immunoglobulin G4-related Sclerosing Cholangitis by Corticosteroids N/A
Recruiting NCT01367821 - Immune Function in Patients With Obstructive Jaundice N/A
Recruiting NCT06456476 - Patients With Obstructive Jaundice In Sohag University Hospital
Completed NCT04385147 - Advanced Endoscopy During COVID-19
Completed NCT02166840 - Metal or Plastic Stents to Relieve Obstruction of Obstructive Jaundice Prior to Resection of Periampullary Tumors. Phase 2
Completed NCT05155475 - Endoscopic Ultrasound Evaluation of the Common Bile Duct in Patients With Obstructive Jaundice Due to Bilio-pancreatic Malignancies (ECCO Trial)
Recruiting NCT03133026 - Cholangioscopic Assessment of Occluded Biliary Stent and Role of Biliary Radiofrequency Ablation N/A
Recruiting NCT01438385 - Interventional Endoscopy Database for Pancreatico-biliary, Gastrointestinal and Esophageal Disorders N/A
Completed NCT01191814 - Comparison of Metal and Plastic Stents for Preoperative Biliary Decompression N/A
Recruiting NCT05246176 - Ultrasonography as a Single Tool for Guided Percutaneous Transhepatic Biliary Drainage in Obstructive Jaundice N/A
Recruiting NCT03977779 - Evaluation of the Use of a Biodegradable Endoprothesis in the Prevention of Post-Endoscopic Retrograde CholoangioPancreatography Pancreatitis N/A
Completed NCT04823832 - Endoscopic Versus Percutaneous Biliary Drainage for Resectable Pancreatic Head Cancer N/A
Completed NCT03376945 - Application of n-3 Fatty to Patient of Jaundice N/A
Completed NCT03510754 - Endoscopic Ultrasound-guided Biliary Drainage for Malignant Biliary Obstruction After Failed ERCP
Not yet recruiting NCT01688375 - The Effect of Ursodeoxycholic Acid in Liver Functional Restoration of Patients With Obstructive Jaundice Phase 2